Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-02-22 @ 8:50 PM
Study NCT ID:
NCT04334993
Status:
UNKNOWN
Last Update Posted:
2021-05-07
First Post:
2020-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Sponsor:
Israeli Medical Association
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-31
First Submit QC Date:
None
Study First Post Date:
2020-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-06
Last Update Post Date:
2021-05-07
Last Update Post Date Type:
ACTUAL